TITRATE (inducTIon for acuTe ulceRATivE Colitis)

PHASE4TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 4, 2019

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions
Colitis, Ulcerative
Interventions
DRUG

Infliximab

infliximab iv 5mg/kg

Trial Locations (7)

Unknown

St Vincent's University Hospital, Dublin

Academic Medical Center, Amsterdam

OLVG Oost, Amsterdam

Radboud UMC, Nijmegen

Klinikk Baerum Sykehus, Bærums verk

Akerhus University Hospital, Lørenskog

Helse Stavanger, Stavanger

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03937609 - TITRATE (inducTIon for acuTe ulceRATivE Colitis) | Biotech Hunter | Biotech Hunter